Search Results - Prithviraj, Prashanth

Precision Medicine: An Optimal Approach to Patient Care in Renal Cell Carcinoma by Sharma, Revati, Kannourakis, George, Prithviraj, Prashanth, Ahmed, Nuzhat

Get full text Get full text Get full text

Determinants of resistance to VEGF-TKI and immune checkpoint inhibitors in metastatic renal cell carcinoma by Sharma, Revati, Kadife, Elif, Myers, Mark, Kannourakis, George, Prithviraj, Prashanth, Ahmed, Nuzhat

Get full text Get full text Get full text

Embryonic Chicken Transplantation is a Promising Model for Studying the Invasive Behavior of Melanoma Cells by Jayachandran, Aparna, McKeown, Sonja J., Woods, Briannyn L., Prithviraj, Prashanth, Cebon, Jonathan

Get full text Get full text Get full text

Combined Inhibition of TGF-β1-Induced EMT and PD-L1 Silencing Re-Sensitizes Hepatocellular Carcinoma to Sorafenib Treatment by Shrestha, Ritu, Prithviraj, Prashanth, Bridle, Kim R., Crawford, Darrell H. G., Jayachandran, Aparna

Get full text Get full text Get full text

CD73 and PD-L1 as Potential Therapeutic Targets in Gallbladder Cancer by Cao, Lu, Bridle, Kim R., Shrestha, Ritu, Prithviraj, Prashanth, Crawford, Darrell H. G., Jayachandran, Aparna

Get full text Get full text Get full text

Eftilagimod alpha, a soluble lymphocyte activation gene-3 (LAG-3) protein plus pembrolizumab in patients with metastatic melanoma by Atkinson, Victoria, Khattak, Adnan, Haydon, Andrew, Eastgate, Melissa, Roy, Amitesh, Prithviraj, Prashanth, Mueller, Christian, Brignone, Chrystelle, Triebel, Frederic

Get full text Get full text Get full text

Monitoring Immune Checkpoint Regulators as Predictive Biomarkers in Hepatocellular Carcinoma by Shrestha, Ritu, Prithviraj, Prashanth, Anaka, Matthew, Bridle, Kim R., Crawford, Darrell H. G., Dhungel, Bijay, Steel, Jason C., Jayachandran, Aparna

Get full text Get full text Get full text

Aberrant pregnancy-associated plasma protein-A expression in breast cancers prognosticates clinical outcomes by Prithviraj, Prashanth, Anaka, Matthew, Thompson, Erik W., Sharma, Revati, Walkiewicz, Marzena, Tutuka, Candani S. A., Behren, Andreas, Kannourakis, George, Jayachandran, Aparna

Get full text Get full text Get full text

Prognostic Role of Immune Checkpoint Regulators in Cholangiocarcinoma: A Pilot Study by Cao, Lu, Prithviraj, Prashanth, Shrestha, Ritu, Sharma, Revati, Anaka, Matthew, Bridle, Kim R., Kannourakis, George, Crawford, Darrell H.G., Jayachandran, Aparna

Get full text Get full text Get full text

Transketolase-like 1 ectopic expression is associated with DNA hypomethylation and induces the Warburg effect in melanoma cells by Jayachandran, Aparna, Lo, Pu-Han, Chueh, Anderly C., Prithviraj, Prashanth, Molania, Ramyar, Davalos-Salas, Mercedes, Anaka, Matthew, Walkiewicz, Marzena, Cebon, Jonathan, Behren, Andreas

Get full text Get full text Get full text

Thrombospondin 1 promotes an aggressive phenotype through epithelial-to-mesenchymal transition in human melanoma by Jayachandran, Aparna, Anaka, Matthew, Prithviraj, Prashanth, Hudson, Christopher, McKeown, Sonja J, Lo, Pu-Han, Vella, Laura J, Goding, Colin R, Cebon, Jonathan, Behren, Andreas

Get full text Get full text

Identifying and targeting determinants of melanoma cellular invasion by Jayachandran, Aparna, Prithviraj, Prashanth, Lo, Pu-Han, Walkiewicz, Marzena, Anaka, Matthew, Woods, Briannyn L., Tan, BeeShin, Behren, Andreas, Cebon, Jonathan, McKeown, Sonja J.

Get full text Get full text Get full text

Reply to ‘Comment on ‘Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy'' by Bowyer, Samantha, Prithviraj, Prashanth, Lorigan, Paul, Larkin, James, McArthur, Grant, Atkinson, Victoria, Millward, Michael, Khou, Muoi, Diem, Stefan, Ramanujam, Sangeetha, Kong, Ben, Liniker, Elizabeth, Guminski, Alexander, Parente, Phillip, Andrews, Miles C, Parakh, Sagun, Cebon, Jonathan, Long, Georgina V, Carlino, Matteo S, Klein, Oliver

Get full text Get full text Get full text